Sediment flow through hydro turbine causes erosion of hydraulic components resulting in drop of turbine efficiency, particularly in hydropower plants of the Himalayan region.
There is still a need of further fundamental research to understand the effects of sediment erosion of turbine components on the flow phenomenon, and developing better designs of hydro turbines to minimize those effects.
The hard abrasive material present in the river water of this region cause rapid erosion of turbine components and affect the performance of turbines, which in turn decreases the efficiency, reliability and operating life of such projects.
Solid particle erosion (SPE) degradation of components in aircraft operating in harsh environments is a well known issue causing severe maintenance and reliability problems.
Regarding the erosion of the pump components, different techniques were used to identify the zones of maximum localized wear and to suggest an approach to reduce it.
It is well known that a fusion device generates dusts due to plasma surface interactions, which cause a significant erosion of plasma facing components.
Operationally, the production of sand is, in general, undesirable as it can restrict productivity, lead to erosion of the completion components, impede wellbore access, and interfere with the operation of downhole equipment.
The In-Vessel Viewing and Metrology System (IVVS) is a fundamental tool for the ITER machine operations, aiming at performing inspections as well as providing information related to the erosion of in-vessel components.
The In-Vessel Viewing and Metrology System (IVVS) is a fundamental tool for the ITER machine operations, aiming at performing inspections as well as providing information related to the erosion of in-vessel components, which in turn is related to the amount of mobilised dust present in the Vacuum Vessel.
Over the same period of time, the joint erosion component of the mTSS did not change in the adalimumab group (mean change 0.0 (SD 1.37)) and decreased slightly in patients who switched from placebo to adalimumab (mean change −0.2 (SD 3.85)).
